Drug Profile
HIV vaccine - GSK/Okairos AG
Latest Information Update: 02 Aug 2023
Price :
$50
*
At a glance
- Originator Okairos AG; University of Oxford
- Class AIDS vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued HIV infections
Most Recent Events
- 26 Feb 2019 Discontinued - Phase-I/II for HIV infections (Prevention, In volunteers) in United Kingdom (Parenteral)